A 6-year safety surveillance of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in South Korea

• المؤلفون الرئيسيون: Soon Min Lee (مؤلف), Jang Hoon Lee (مؤلف), Eun Song Song (مؤلف), Sung Jin Kim (مؤلف), Joon Hyung Kim (مؤلف), Rupert W. Jakes (مؤلف), Raghavendra Devadiga (مؤلف), Moon Sung Park (مؤلف)
• التنسيق: كتاب
• منشور في: Taylor & Francis Group, 2018-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

In 2010, Korea introduced 10-valent pneumococcal conjugate vaccine for children aged 6 weeks to 5 years against invasive disease caused by Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F and cross-reactive 19A. The aim of this 6-year real-world study of 646 healthy Korean c...